Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Analysis of Different Ways of Drainage for Obstructive Jaundice Caused by Hilar Cholangiocarcinoma

  • Xu, Chuan (Department of Interventional Radiology, Subei People's Hospital of Jiangsu Province, Clinical Hospital of Yangzhou University) ;
  • Lv, Peng-Hua (Department of Interventional Radiology, Subei People's Hospital of Jiangsu Province, Clinical Hospital of Yangzhou University) ;
  • Huang, Xin-En (Department of Chemotherapy, Jiangsu Cancer Hospital & Institute of Cancer Research, Nanjing Medical University) ;
  • Wang, Shu-Xiang (Department of Interventional Radiology, Subei People's Hospital of Jiangsu Province, Clinical Hospital of Yangzhou University) ;
  • Sun, Ling (Department of Interventional Radiology, Subei People's Hospital of Jiangsu Province, Clinical Hospital of Yangzhou University) ;
  • Wang, Fu-An (Department of Interventional Radiology, Subei People's Hospital of Jiangsu Province, Clinical Hospital of Yangzhou University)
  • Published : 2014.07.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objective: To evaluate the prognosis of different ways of drainage for patients with obstructive jaundice caused by hilar cholangiocarcinoma. Materials and Methods: During the period of January 2006- March 2012, percutaneous transhepatic catheter drainage (PTCD)/ percutaneous transhepatic biliary stenting (PTBS) were performed for 89 patients. According to percutaneous transhepatic cholangiography (PTC), external drainage was selected if the region of obstruction could not be passed by guide wire or a metallic stent was inserted if it could. External drainage was the first choice if infection was diagnosed before the procedure, and a metallic stent was inserted in one week after the infection was under control. Selection by new infections, the degree of bilirubin decrease, the change of ALT, the time of recurrence of obstruction, and the survival time of patients as the parameters was conducted to evaluate the methods of different interventional treatments regarding prognosis of patients with hilar obstruction caused by hilar cholangiocarcinoma. Results: PTCD was conducted in 6 patients and PTBS in 7 (p<0.05). Reduction of bilirubin levels and ALT levels was obvious after the procedures (p<0.05). The average survival time with PTCD was 161 days and with PTBS was 243 days (p<0.05). Conclusions: With both drainage procedures for obstructive jaundice caused by hilar cholangiocarcinoma improvement in liver function was obvious. PTBS was found to be better than PTCD for prolonging the patient survival.

Keywords

References

  1. Butthongkomvong K, Sirachainan E, Jhankumpha S, et al(2013). Treatment outcome of palliative chemotherapy in inoperable cholangiocarcinoma in Thailand. Asian Pac J Cancer Prev. 14, 3565-8. https://doi.org/10.7314/APJCP.2013.14.6.3565
  2. Born P, Rosch T, Bruhi K et al (1998). Long-term results of endoscopic treatment of biliary duct obstruction due topancreatic disease. Hepatogastroenterology, 45, 833-9
  3. Burke DR, Lewis CA, Cardella JF, et al (2003). Qualityimprovement guidelines for percutaneous transhepaticcholagiography and biliary, J Vasc Interv radiol, 14, 243-6.
  4. Chong RJ, Abdullah MS, Hossain MM, et al (2013). Risingincidence of primary liver cancer in Brunei Darussalam. Asian Pac J Cancer Prev, 14, 3473-7. https://doi.org/10.7314/APJCP.2013.14.6.3473
  5. Dambraukas Z, Paskauskas S, Lizdenis P, et al (2003). Percutaneous transhepatic biliary stenting: the firstexperience and results of the Hospital of Kaunas University of Medicine. Med (Kaunas), 44, 969-976.
  6. DA Westwood, C Fernando, Sj Connor, et al (2010). external percutaneous transhepatic billary drainage for malignantbiliary obstruction:a retrospective analysis. J Med Imaging Radiat Oncol, 54, 108-110. https://doi.org/10.1111/j.1754-9485.2010.02147.x
  7. Duangsong R, Promthet S, Thaewnongiew K (2013). Development of a community-based approach to opisthorchiasis control.Asian Pac J Cancer Prev. 14, 7039-43. https://doi.org/10.7314/APJCP.2013.14.11.7039
  8. E.A.de Jong, A. Moelker, T. Leertouwer, et al (2013).Percutaneous Transhepatic Biliary Drainage in Patients with Postsurgical Bile Leakage and Nondilated Intrahepatic Bile Ducts. Dig Surg, 30, 444-450. https://doi.org/10.1159/000356711
  9. Hatzidakis AA, Testis D, Chrysou E, et al (2001). Nitinolstents for palliative treatment of malignant obstructivejaundice:should we stent the sphincter of Oddi in every case?Cardiovase Intervent Radio, 24, 245-8 https://doi.org/10.1007/s00270-001-0030-x
  10. He P, Shi JS, Chen WK, et al (2002). Multivariate statistical analysis of clinicopathologic factors influencing survival of patients with bile duct carcinoma. Worlgd J gastroenterol,8, 943-6
  11. Huang Q, Liu L, Liu CH, et al (2013). MicroRNA-21 regulates the invasion and metastasis in cholangiocarcinoma and maybe a potential biomarker for cancer prognosis. Asian Pac J Cancer Prev. 14, 829-34. https://doi.org/10.7314/APJCP.2013.14.2.829
  12. Hussain SM, Al-Jashamy KA (2013). Determination of chemicalcomposition of gallbladder stones and their association withinduction of cholangiocarcinoma. Asian Pac J Cancer Prev. 14, 6257-60. https://doi.org/10.7314/APJCP.2013.14.11.6257
  13. Ho CS, Warkentin AE (2013). Evidence-based decompression in malignant biliary obstruction. Korean J Radiol, 13, 56-61.
  14. Iruarrizaga E, Azkoma E, Martinez, et al (2011). Percutaneous transhepatic biliary drainage (PTBD) and endoscopicretrograde cholangiopancreatography (ERCP) for malignantobstructive jaundice (OJ) in advanced digestive cancers. J Clinical Oncol, 29, 348. https://doi.org/10.1200/JCO.2010.34.1545
  15. Kamsa-ard S, Laopaiboon M, Luvira V, et al (2013). Associationbetween praziquantel and cholangiocarcinoma in patients infected with Opisthorchis viverrini: a systematic reviewand meta-analysis. Asian Pac J Cancer Prev. 14, 7011-6. https://doi.org/10.7314/APJCP.2013.14.11.7011
  16. Manwong M, Songserm N, Promthet S, et al (2013). Risk factorsfor cholangiocarcinoma in the lower part of Northeast Thailand: a hospital-based case-control study. Asian Pac J Cancer Prev. 14, 5953-6. https://doi.org/10.7314/APJCP.2013.14.10.5953
  17. Qian XJ, Zhai RY, Dai DK, et al (2006). Treatment of malignant biliary obstruction by combined percutaneous transhepatic biliary drainage with local tumor treatment. World J gastroenterol, 12, 331-335.
  18. Prachayakul V, Chaisayan S, Aswakul P, et al (2013). Clinical characteristics and treatment outcomes of patients withunresectable cholangiocarcinoma in Thailand: are theredifferences dependent on stent type? Asian Pac J Cancer Prev. 14, 529-32. https://doi.org/10.7314/APJCP.2013.14.1.529
  19. Saengsawang P, Promthet S, Bradshaw P (2013). Infectionwith Opisthorchis viverrini and use of praziquantel among a working-age population in northeast Thailand. Asian Pac J Cancer Prev. 14, 2963-6. https://doi.org/10.7314/APJCP.2013.14.5.2963
  20. Shin Ahn, Yoon-seon Lee, Kyung Soo Lin, et al (2013). Malignant biliary obstructions can we predict immediatepostprocedural cholangitis after percutaneous biliarydrainage? Support Care Cancer, 21, 2321-6. https://doi.org/10.1007/s00520-013-1796-5
  21. Simmons DT, Baron TH, Petersen BT, et al (2006). A novel endoscopic approach to brachytherapy in the management of Hilar cholangiocarcinoma. Am J Gastroenterol, 64, 1792-6.
  22. Sriraksa R, Limpaiboon T (2013). Histone deacetylasesand their inhibitors as potential therapeutic drugs forcholangiocarcinoma - cell line findings. Asian Pac J Cancer Prev. 14, 2503-8. https://doi.org/10.7314/APJCP.2013.14.4.2503
  23. Srikoon P, Kariya R, Kudo E, et al (2013). Diethyldithiocarbamatesuppresses an NF-kappaB dependent metastatic pathway in cholangiocarcinoma cells. Asian Pac J Cancer Prev. 14, 4441-6. https://doi.org/10.7314/APJCP.2013.14.7.4441
  24. Sriputtha S, Khuntikeo N, Promthet S, et al (2013). Survival rate of intrahepatic cholangiocarcinoma patients after surgical treatment in Thailand. Asian Pac J Cancer Prev. 14, 1107-10. https://doi.org/10.7314/APJCP.2013.14.2.1107
  25. Subrungruanga I, Thawornkunob C, Chawalitchewinkoon-Petmitrc P, et al (2013). Gene expression profiling of intrahepatic cholangiocarcinoma. Asian Pac J Cancer Prev. 14, 557-63. https://doi.org/10.7314/APJCP.2013.14.1.557
  26. Thunyaharn N, Promthet S, Wiangnon S, et al (2013). Survival of cholangiocarcinoma patients in northeastern Thailand after supportive treatment. Asian Pac J Cancer Prev. 14, 7029-32. https://doi.org/10.7314/APJCP.2012.14.11.7029
  27. Todoroki T (2000). Chemotherapy for bile duct carcinomain the light of adjuvant chemotherapy to surgery. Hepatogastroenterology, 47, 644-649.
  28. Woradet S, Promthet S, Songserm N, et al (2013). Factorsaffecting survival time of cholangiocarcinoma patients: a prospective study in Northeast Thailand. Asian Pac J Cancer Prev. 14, 1623-7. https://doi.org/10.7314/APJCP.2013.14.3.1623
  29. Xu C, Huang XE, Wang SX et al (2014). Drainage aloneor combined with anti-tumor therapy for treatment ofobstructive jaundice caused by recurrence and metastasisafter primary tumor resection. Asian Pac J Cancer Prev. 15, 2681-4. https://doi.org/10.7314/APJCP.2014.15.6.2681
  30. Yu Li sol, Chang Won Kim, et al (2010). Early Infectious Complications of Percutaneous Metallic Stent Insertionfor Malignant Biliary Obstruction. AJR Am J Roentgenol,194, 261-5. https://doi.org/10.2214/AJR.09.2474

Cited by

  1. Comparison of Infection between Internal-External and External Percutaneous Transhepatic Biliary Drainage in Treating Patients with Malignant Obstructive Jaundice vol.16, pp.6, 2015, https://doi.org/10.7314/APJCP.2015.16.6.2543
  2. Safety and Efficacy of a Mouth-Rinse with Granulocyte Colony Stimulating Factor in Patients with Chemotherapy-Induced Oral Mucositis vol.17, pp.1, 2016, https://doi.org/10.7314/APJCP.2016.17.1.413
  3. A Clinical Study on Juheli (Recombinant Human Interleukin - 11) in the Second Prevention of Chemotherapy Induced Thrombocytopenia vol.17, pp.2, 2016, https://doi.org/10.7314/APJCP.2016.17.2.485
  4. Infections in Cancer Patients with Solid Tumors: A Review vol.6, pp.1, 2017, https://doi.org/10.1007/s40121-017-0146-1